Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres

Area of Science:

• Materials Science
• Pharmaceutical Technology
• Biomedical Engineering

Background:

• Biodegradable polymers like poly-D,L-lactide-co-glycolide (PLGA) are crucial for controlled drug delivery systems.
• Clonazepam's solubility presents challenges for microencapsulation, necessitating evaluation of different preparation techniques.
• PLGA copolymers vary in molecular weight and properties, influencing drug release profiles.

Purpose of the Study:

• To prepare and characterize biodegradable PLGA microspheres for controlled release of clonazepam.
• To evaluate the suitability of emulsification solvent evaporation and spray-drying techniques for clonazepam microencapsulation.
• To investigate the effect of PLGA molecular weight on clonazepam release kinetics.

Main Methods:

• Microencapsulation of clonazepam using PLGA copolymers (RG 502H, RG 503H, RG 503) via emulsification solvent evaporation and spray-drying.
• Characterization of microspheres including morphology, physicochemical properties (Differential Scanning Calorimetry - DSC), and in vitro dissolution testing.
• Comparison of the two microencapsulation techniques and assessment of polymer molecular weight impact on drug release.

Main Results:

• Spray-drying was the only suitable method for encapsulating clonazepam in PLGA microspheres.
• Microsphere characterization confirmed successful preparation and provided insights into their properties.
• In vitro dissolution studies demonstrated that higher molecular weight PLGA polymers resulted in a more sustained release of clonazepam.

Conclusions:

• Spray-drying is an effective method for producing PLGA microspheres for controlled clonazepam delivery.
• The molecular weight of the PLGA polymer significantly influences the drug release rate, with higher molecular weights promoting sustained release.
• These findings contribute to the development of advanced drug delivery systems for poorly soluble drugs.